AXSM vs SHW · rev $409.6M vs P/E 29, rev $12.46B
Axsome Therapeutics Inc (AXSM) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
AXSM currently screens at market cap $11.96B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the AXSM and SHW stock pages for the full models.
Not investment advice.